Acquired vWD was found in a 2% yr. old girl who presented with ecchymoses and conjunctival hemorrhages. Marked splenomegaly was present. Diffuse hemangiomatous transformation of the spleen suspected clinically, by CT scan and antiography, was confirmed at surgery. Coagulation studies were done at diagnosis, pre-and post-DDAVP infusion (0.3 mcglkg) and 1 week post-splenectomy.
BT Plt Ct I VIII vWF:Ag vWF VIII (min) (~103) (mgldl) (u/ml) (ulml) (ulml) Multimers -- Hepatocellular carcinoma has been associated with various coagulation abnormalities, including dysfibrinogenemia and production of a biochemically-alinormal prothrombin. A 10 year old girl presented with recent onset of severe epistaxis and was found to have hepatocellular carcinoma. The bleeding time (Ivy method) was prolonged (20 min.) and factor VIII-related antigen was electro~horetically abnormal, while factor VIIIprocoa&lant actiii ty protein was normal. Platelet aaureuation studies demonstrated abnormal and delayed agglutination in the presence of ristocetin ( 0 . 8 -1 . 0 mg/ml), with essentially normal agglutination with collagen, ADP, and epinephrine. A major hepatic resection (trisegmentectomy) was performed, and the tumor was completely removed. Substantial bleeding was encountered at operation despite pre-treatment with cryoprecipitate and platelet infusions, but following surgery there were no further bleeding symptoms and the bleeding time and pla-. ~ A maiked loss of myelin and axons in-the white matter, and $ ramtelet aggregation tests returned to normal. he tumor ifications within, and width of, the molecular layer are also was established in long-term culture to seek evidence noted. Rare large monwwclear cells at the granular layer-white for a postulated tumor-derived anticoagulant in this pamatter junction were observed. In our two patients with select- The pathogenesis of JCML was studied in 9 pts. Using cell cultures and chromosome markers, marrow and peripheral blood consistently showed 2 features: impaired expression of normal hematopoietic progenitors (CFU-E, BFU-E, CFU-GEMM), and excessive clonal proliferation of monocyte-macrophage elements whose growth was independent of added CSA or an adherent cell fraction. In contrast, 5 adult CML's (~hl+) showed nomal hematopoiesis in vitro and CSA-dependent CFU-C growth similar to controls. Using monoclonal antibodies, cloned JCML cells were positive for surface antigens Ia, Mo2, LeuM1, LeuM3, and OKM1, thus confirming monocytic lineage. Characterization studies on cloned cell populations revealed a wide spectrum of features, some mature (latex ingestion, non-specific esterase positive, sensitivity to growth inhibition by PGE2 and to gene-cloned interferon), and some primitive (negative for lysozyme, 6-glucuronidase, procoagulant activity, and plasminogen activator). Functionally, JCML cells markedly impaired hematopoiesis in vitro from normal marrow; thus, co-cultures of normal marrow with JCML adherent cells, or fresh JCML marrow, or JCtU plasma, resulted in suppressed normal colony formation. We conclude that JCML is a malignant clonal disorder of monocytic lineage, and that cell cultures provide a reliable and specific diagnosric test. The mechanism of hematopoietic failure in JCML is likely mediated by an inhibitory monokine secreted by JCML cells. Dept. of Pediatrics and Internal Medicine, University of Manitoba A boy, age 5, presented with easy bleeding since birth and was found to have a long bleeding time, thrombocytopenia and abnormal platelet function (absent second wave aggregation with epinephrine, decreased aggregation to collagen but a normal first wave response to ADP and normal aggregation to arachidonic acid). His bone marrow was normal. At age 64 years this boy developed progressive anemia, thrombocytopenia and splenomegaly, and was diagnosed as having juvenile chronic myelogenous leukemia. This child's father, grandfather and two of the grandfather's sisters were found to have a similar bleeding defect with a long bleeding time, mild thrombocytopenia, abnormal aggregation pattern similar to the propositus, and deficiency of platelet ADP, serotonin and dense bodies. Thrombin-induced arachidonic acid release, conversion of arachidonic acid to thromboxane B2 and phosphorylation of platelet proteins were normal. One of the grandfather's sisters with a lifelong bleeding tendency and a platelet storage pool deficiency documented at age 38, developed myelomonocytic leukemia at age 41. Another sister and a brother of the grandfather, bleeding history uncertain, died at ages 8 and 23 of leukemia. The great grandmother and her sister both with lifelong bleeding histories had died of leukemia. The findings suggest this family has an inherited platelet storage pool deficiency associated with an increased susceptibility to i the development of a myeloproliferative disorder.
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